Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.44 |
| ▸ | FABP7 | O15540 | 2/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | MDM4 | O15151 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1436990 | 0.91 | KMT2A (0.56) | KMT2AFABP5FABP7CA1CA2 | |
| Hydrochloric Acid SCHEMBL2174098 | 0.89 | KMT2A (0.55) | KMT2AFABP5FABP7CA1CA2 | |
| Bromide SCHEMBL15671138 | 0.89 | KMT2A (0.55) | KMT2AFABP5FABP7CA1CA2 | |
| Trifluoroacetic Acid SCHEMBL31247371 | 0.85 | KMT2A (0.42) | KMT2AFABP5FABP7DPP8DPP7 | |
| Trifluoroacetic Acid SCHEMBL4363454 | 0.81 | MDM4 (0.55) | KMT2AMDM4TP53CASP3MDM2 | |
| SCHEMBL1901193 | 0.80 | KMT2A (0.53) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL30983194 | 0.80 | CASP3 (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL7123965 | 0.80 | CASP3 (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL9188706 | 0.80 | CASP3 (0.50) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL8453691 | 0.79 | KMT2A (0.52) | KMT2AFABP5FABP7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1310510-B1 | Topologically segregated, encoded solid phase libraries | AVENTIS PHARMA INC (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1310510-A2 | Topologically segregated, encoded solid phase libraries | SELECTIDE CORPORATION (US) | 2003-05-14 | — | — | EP | disclosed |
| EP-0705279-B1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 2003-02-19 | — | — | EP | disclosed |
| US-6090912-A | MULTIPLICITY OF SEPARATE SOLID SUPPORTS WITH SURFACE HAVING SUCEPTIBLE LINKER TO SINGLE SPECIES OF TEST COMPOUND AND WITH INTERIOR HAVING ATTACHED NON-CLEAVABLE CODING MOLECULE; FOR SCREENING LIGANDS OR ACCEPTORS | SELECTIDE CORPORATION (US) | 2000-07-18 | — | — | US | disclosed |
| EP-0705279-A4 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORP (US) | 1999-03-24 | — | — | EP | disclosed |
| US-5840485-A | SYNTHETIC TEST COMPOUNDS ATTACHED TO SEPARATE PHASE SYNTHESIS SUPPORTS THAT ALSO CONTAIN CODING MOLECULES THAT ENCODE THE STRUCTURE OF THE SYNTHETIC TEST COMPOUND | SELECTIDE CORPORATION (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0705279-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1996-04-10 | — | — | EP | disclosed |
| WO-1994028028-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |